<?xml version="1.0" encoding="UTF-8"?>
<ref id="B105-ijms-22-00962">
 <label>105.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>C.Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.X.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>X.H.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>W.W.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Phlorizin exerts direct protective effects on palmitic Acid (PA)-induced endothelial dysfunction by activating the PI3K/AKT/eNOS signaling pathway and increasing the levels of Nitric Oxide (NO)</article-title>
  <source>Med. Sci. Monit. Basic Res.</source>
  <year>2018</year>
  <volume>24</volume>
  <fpage>1</fpage>
  <lpage>9</lpage>
  <pub-id pub-id-type="doi">10.12659/MSMBR.907775</pub-id>
  <pub-id pub-id-type="pmid">29307883</pub-id>
 </element-citation>
</ref>
